Salter A

ORCID: 0000-0002-1088-110X · 2 papers in corpus · active 2022
2022
Journal of central nervous system disease ·doi:10.1177/11795735221109674

BackgroundThere is currently limited literature addressing the reporting of alopecia in multiple sclerosis (MS) patients treated with disease-modifying therapies (DMTs). Anecdotal reports of hair thinning from patients on various DMTs promp…

2022
Neurology ·doi:10.1212/wnl.0000000000200931

Background and objectivesMost studies of health-related quality of life (HRQoL) in multiple sclerosis (MS) have been cross-sectional. The few longitudinal studies have not accounted for potential heterogeneity in HRQOL trajectories. There m…